| Literature DB >> 16713590 |
Eriko Samura1, Mikio Shoji, Takeshi Kawarabayashi, Atsushi Sasaki, Etsuro Matsubara, Tetsuro Murakami, Xu Wuhua, Shuta Tamura, Masaki Ikeda, Koich Ishiguro, Takaomi C Saido, David Westaway, Peter St George Hyslop, Yasuo Harigaya, Koji Abe.
Abstract
Abeta amyloidosis and tauopathy are characteristic changes in the brain of Alzheimer's disease. Although much evidence suggests that Abeta deposit is a critical initiation factor, the pathological pathway between Abeta amyloidosis and tau accumulation remains unclear. Tau accumulation was examined in the doubly transgenic mouse (APP-PS) expressing betaAPP(KM670/671NL) (Tg2576) and presenilin-1 L286V (PS-1 L286Vtg). Accelerated and enhanced Abeta amyloid deposits were detected from 8 weeks. Tau accumulation appeared at 4.5 months and markedly increased in dystrophic neurites around Abeta amyloid. Accumulated tau was phosphorylated, conformationally altered, and argyrophilic. Expression of tau and accumulation of sarkosyl-insoluble phosphorylated tau were increased in APP-PS brains compared with those of Tg2576 mice. Straight or twisted tubules mimicking paired helical filament were revealed at electron microscopic level in 16-month-old APP-PS. These findings suggest that mutant presenilin-1 accelerated Abeta-induced tauopathy and further promoted fibril formation of tau.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16713590 DOI: 10.1016/j.brainres.2005.12.134
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252